Over the last 12 months, Beta Bionics insiders reported no purchases and 12 sales totaling $755K across SEC Form 4 filings. 58% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Feider StephenChief Financial Officer · O | ▼ Sale | 10,000 | $17.04 | $170K | -5.7% | plan · 2 tranches |
| Jun 24, 2026 | Hopman MarkChief Commercial Officer · O | ▼ Sale | 1,258 | $15.01 | $19K | -1% | plan |
| Jun 24, 2026 | Jones ChristyD | ▼ Sale | 1,406 | $15 | $21K | -5.1% | plan |
| Jun 4, 2026 | Hopman MarkChief Commercial Officer · O | ▼ Sale | 275 | $12.31 | $3K | -0.2% | plan |
| Jun 4, 2026 | Jones ChristyD | ▼ Sale | 2,811 | $14 | $39K | -9.3% | plan |
| Jun 2, 2026 | Mensinger MikeChief Product Officer · O | ▼ Sale | 4,378 | $12.61 | $55K | -2.3% | — |
| Jun 2, 2026 | Hopman MarkChief Commercial Officer · O | ▼ Sale | 5,329 | $12.61 | $67K | -3.9% | — |
| Jun 2, 2026 | Russell Steven JonChief Medical Officer · O | ▼ Sale | 4,222 | $12.61 | $53K | -2.4% | — |
| Jun 2, 2026 | Feider StephenChief Financial Officer · O | ▼ Sale | 6,676 | $12.61 | $84K | -3.9% | — |
| Jun 2, 2026 | Saint SeanPresident & CEO · O·D | ▼ Sale | 16,872 | $12.61 | $213K | -3.9% | — |
| May 21, 2026 | Jones ChristyD | ▼ Sale | 1,998 | $9.95 | $20K | -13.1% | plan |
| May 21, 2026 | Lezack AdamD | ▼ Sale | 1,000 | $9.95 | $10K | -8% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BBNX feed.